Permanent cardiac pacing as primary therapy for neurocardiogenic (reflex) syncope.
Recurrent reflex (or neurocardiogenic) syncope is a common clinical problem. Pacemaker therapy has been advocated as a potential therapy in severe or drug refractory cases of reflex syncope, while others have suggested that it may provide a benefit if employed as a primary therapeutic modality. The following paper reviews the concepts behind pacemaker therapy for reflex syncope and the results of various clinical trials that have evaluated its potential utility as a primary therapeutic modality.
Electrophysiology Section, Division of Cardiology, Dept. of Medicine, Medical College of Ohio, Toledo, OH 43614, USA.
Daniel J
DJ
Kosinski
Blair P
BP
Grubb
Douglas A
DA
Wolfe
D006801:Humans; D010138:Pacemaker, Artificial; D016032:Randomized Controlled Trials as Topic; D019462:Syncope, Vasovagal / Q000601:surgery*